Cue Health Q4 2023 Adj EPS $(0.32) Beats $(0.44) Estimate, Sales $18.798M Beat $17.681M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cue Health (NASDAQ:HLTH) reported Q4 2023 adjusted EPS of $(0.32), surpassing the $(0.44) estimate, with sales of $18.798M exceeding the $17.681M forecast. However, this represents an 87.19% decrease in sales compared to the same period last year.

March 13, 2024 | 8:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cue Health reported better-than-expected Q4 2023 earnings and sales, but experienced a significant decrease in sales year-over-year.
The positive earnings and sales beat are likely to have a short-term positive impact on HLTH's stock price, as beating estimates can lead to increased investor confidence. However, the significant year-over-year sales decrease may temper optimism, suggesting a cautious outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100